SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-174720
Filing Date
2019-06-17
Accepted
2019-06-17 16:03:56
Documents
5
Effectiveness Date
2019-06-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A d762221ddefa14a.htm DEFA14A 18080
2 GRAPHIC g762221page002.jpg GRAPHIC 117882
3 GRAPHIC g762221page003.jpg GRAPHIC 230524
4 GRAPHIC g762221page004.jpg GRAPHIC 44705
5 GRAPHIC g762221page005.jpg GRAPHIC 5484
  Complete submission text file 0001193125-19-174720.txt   564954
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 19901444
SIC: 2836 Biological Products, (No Diagnostic Substances)